COVID – 19 | Vaccination Update – Day 473

ad
Measles Rubella vaccination 2nd phase campaign rolled out
Vaccination

India’s COVID-19 vaccination coverage has crossed 189.46Crore(1,89,46,76,946today. More thannearly 3lakh (3,93,359) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10405383
2nd Dose 10019302
Precaution Dose 4849361
FLWs 1st Dose 18416159
2nd Dose 17544424
Precaution Dose 7733272
Age Group 12-14 years 1st Dose 29495504
2nd Dose 8026873
Age Group 15-18 years 1st Dose 58555317
2nd Dose 42643156
Age Group 18-44 years 1st Dose 555864944
2nd Dose 479542508
Precaution Dose 206044
Age Group 45-59 years 1st Dose 202950824
2nd Dose 188311154
Precaution Dose 652644
Over 60 years 1st Dose 126887791
2nd Dose 117330998
Precaution Dose 15241288
Cumulative 1st dose administered 1002575922
Cumulative 2nd dose administered 863418415
Precaution Dose 28682609
Total 1894676946

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 3rd May, 2022 (473rdDay)
HCWs 1st Dose 9
2nd Dose 142
Precaution Dose 4390
FLWs 1st Dose 19
2nd Dose 267
Precaution Dose 9936
Age Group 12-14 years 1st Dose 45742
2nd Dose 51815
Age Group 15-18 years 1st Dose 7123
2nd Dose 31744
Age Group 18-44 years 1st Dose 13484
2nd Dose 112192
Precaution Dose 9139
Age Group 45-59 years 1st Dose 3401
2nd Dose 26922
Precaution Dose 17968
Over 60 years 1st Dose 2914
2nd Dose 17632
Precaution Dose 38520
Cumulative 1st dose administered 72692
Cumulative 2nd dose administered 240714
Precaution Dose 79953
Total 393359

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Be the first to comment

Leave a Reply